R1	multi Arg1:T4 Arg2:T5	
*	OR T2 T3
R2	Has_value Arg1:T2 Arg2:T1	
R3	Has_temporal Arg1:T2 Arg2:T4	
R5	Has_qualifier Arg1:T8 Arg2:T11	
R6	Has_temporal Arg1:T8 Arg2:T10	
*	OR T13 T19 T18 T17 T16 T15 T14 T20
R8	Subsumes Arg1:T8 Arg2:T13	
*	OR T25 T26
R9	AND Arg1:T24 Arg2:T25	
R10	Has_temporal Arg1:T24 Arg2:T22	
R12	Has_value Arg1:T30 Arg2:T31	
*	OR T30 T33
R14	Has_temporal Arg1:T30 Arg2:T34	
*	OR T37 T38
R15	Has_qualifier Arg1:T37 Arg2:T36	
R16	AND Arg1:T37 Arg2:T39	
R18	Has_temporal Arg1:T37 Arg2:T29	
R4	Has_qualifier Arg1:T32 Arg2:T28	
R7	Has_index Arg1:T44 Arg2:T45	
R11	Has_temporal Arg1:T43 Arg2:T44	
R13	Has_mood Arg1:T43 Arg2:T42	
R17	Has_negation Arg1:T42 Arg2:T41	
R19	Has_negation Arg1:T32 Arg2:T23	
*	OR T32 T43
T1	Value 3 11	positive
T2	Measurement 12 17;27 31	HIV 1 test
T3	Measurement 21 31	HIV 2 test
T4	Temporal 32 44	at screening
T5	Reference_point 35 44	screening
T8	Condition 72 84	skin disease
T10	Temporal 49 56	history
T11	Qualifier 60 71	significant
T12	Undefined_semantics 60 71	significant
T13	Condition 113 117	rash
T14	Condition 121 130	eruptions
T15	Condition 132 146	drug allergies
T16	Condition 148 160	food allergy
T17	Condition 162 172	dermatitis
T18	Condition 174 180	eczema
T19	Condition 182 191	psoriasis
T20	Condition 196 205	urticaria
T22	Temporal 210 217	history
T24	Condition 221 228	allergy
T25	Drug 267 280	sulphonamides
T26	Drug 285 296	penicillins
T30	Procedure 705 719	pregnancy test
T31	Value 696 704	positive
T33	Observation 723 737	breast feeding
T34	Temporal 738 750	at screening
T29	Temporal 301 311	previously
T36	Qualifier 325 347	clinically significant
T37	Condition 348 355	allergy
T38	Condition 359 375	hypersensitivity
T39	Drug 390 434	excipients of the investigational medication
T7	Person 466 472	female
T9	Condition 484 506	childbearing potential
T23	Negation 507 514	without
T28	Qualifier 522 531	effective
T32	Procedure 532 557	nonhormonal birth control
T41	Negation 570 573	not
T42	Mood 574 604	willing to continue practicing
T43	Procedure 611 632	birth control methods
T44	Temporal 633 691	for at least 30 days after the end of the treatment period
T45	Reference_point 660 691	the end of the treatment period
